RenovoRx, Inc. Files 8-K: Material Agreement & Other Events
Ticker: RNXT · Form: 8-K · Filed: Apr 9, 2024 · CIK: 1574094
| Field | Detail |
|---|---|
| Company | Renovorx, INC. (RNXT) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001, $1.4075, $1.22, $50,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-event, filing
TL;DR
RenovoRx filed an 8-K for a material agreement and other events - check for details.
AI Summary
On April 9, 2024, RenovoRx, Inc. reported the entry into a material definitive agreement. The company also disclosed other events and filed financial statements and exhibits. The specific details of the agreement and financial information were not fully elaborated in the provided text, but the filing indicates a significant corporate event.
Why It Matters
This filing signals a significant corporate development for RenovoRx, Inc., potentially impacting its business operations, financial standing, and future strategic direction.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which could represent significant opportunities or risks for the company, but the specifics are not detailed in the provided text.
Key Players & Entities
- RenovoRx, Inc. (company) — Registrant
- April 9, 2024 (date) — Date of Report
- April 4, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 27-1448452 (identifier) — IRS Employer Identification No.
- 4546 El Camino Real , Suite B1 Los Altos , CA 94022 (address) — Registrant's principal executive offices
- (650) 284-4433 (phone_number) — Registrant's principal executive offices phone number
FAQ
What is the nature of the material definitive agreement entered into by RenovoRx, Inc.?
The provided text states that RenovoRx, Inc. entered into a material definitive agreement, but the specific details of this agreement are not elaborated in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 4, 2024.
What is the principal executive office address for RenovoRx, Inc.?
The principal executive office address for RenovoRx, Inc. is 4546 El Camino Real, Suite B1, Los Altos, CA 94022.
What is the IRS Employer Identification Number for RenovoRx, Inc.?
The IRS Employer Identification Number for RenovoRx, Inc. is 27-1448452.
What are the main items reported in this 8-K filing?
This 8-K filing reports the entry into a material definitive agreement, other events, and financial statements and exhibits.
Filing Stats: 1,518 words · 6 min read · ~5 pages · Grade level 13.6 · Accepted 2024-04-09 16:15:40
Key Financial Figures
- $0.0001 — he "Shares") of common stock, par value $0.0001 per share, of the Company (the "Common
- $1.4075 — eries A Warrant and Series B Warrant is $1.4075. The Subscription Agreements contain
- $1.22 — t Shares for an exercise price equal to $1.22 per share. The Series B Warrants are
- $50,000 — will also pay the Placement Agent up to $50,000 for its expenses in connection with the
Filing Documents
- form8-k.htm (8-K) — 46KB
- ex99-1.htm (EX-99.1) — 22KB
- 0001493152-24-014069.txt ( ) — 243KB
- rnxt-20240409.xsd (EX-101.SCH) — 3KB
- rnxt-20240409_lab.xml (EX-101.LAB) — 33KB
- rnxt-20240409_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RenovoRx, Inc. Date: April 9, 2024 By: /s/ Shaun Bagai Name: Shaun R. Bagai Title: Chief Executive Officer